Swiss Stocks Steady, Led By Drug Makers

(RTTNews) - Swiss stocks saw little movement on Monday, weighed down by global economic jitters and renewed concerns about the situation in Ukraine.

Health care majors Roche and Novartis continued to perform well, but Transocean and UBS were firmly negative on the day.

The Swiss Market Index inched up 0.01 percent to 8,796.41, staying near a record high from earlier in the month.

U.S. company Danaher Corp said it will buy Nobel Biocare Holding in an all-cash deal valued at about $2.2 billion. Nobel shares slipped 5.8 percent.

Cargill filed suit against Swiss firm Syngenta in Louisiana state court. Cargill says that Syngenta's sale of bioengineered corn seeds that weren't approved in China cost Cargill $90 million when Beijing rejected its corn shipments. Syngenta slipped 0.6 percent.